Corvus Pharmaceuticals (CRVS) Non-Current Assets (2015 - 2026)
Corvus Pharmaceuticals' Non-Current Assets was $695,000 in Q2 2026, down 37.3% from $1.11 million a year earlier and down 12.9% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Non-Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Corvus Pharmaceuticals came in at $904,000, down 31.3% from FY2024.
- Non-Current Assets has now declined for five consecutive years, with a five-year compound annual growth rate of -53.2% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $1.32 million in FY2024 (-7.8%), $1.43 million in FY2023 (-13.6%), $1.65 million in FY2022 (-95.7%) and $38.14 million in FY2021 (-5.1%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets in data going back to Q4 2015.
- Compared with a year earlier, Non-Current Assets has declined for seven straight quarters, with an average decline of 18.3% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q3 2024 (growth of 1.0%); the worst was Q2 2023 (a decline of 95.7%).
- Per Business Quant data, CRVS's Non-Current Assets in the three quarters before Q2 2026 was $798,000 (Q1 2026), $904,000 (Q4 2025) and $1.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Corvus Pharmaceuticals | 998.52 Mn | 486.96 Mn | - | 695,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 695,000.00 |
| Mar 31, 2026 | 798,000.00 |
| Dec 31, 2025 | 904,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.33 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 22.65 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Sep 30, 2022 | 29.08 Mn |
| Jun 30, 2022 | 33.66 Mn |
| Mar 31, 2022 | 36.92 Mn |
| Dec 31, 2021 | 38.14 Mn |
| Sep 30, 2021 | 40.57 Mn |
API Access
Corvus Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();